EDGAR Filing Documents for 0001013762-23-006323

Form 8-K - Current report:

SEC Accession No. 0001013762-23-006323

Filing Date

2023-10-24

Accepted

2023-10-24 16:48:59

Documents

Period of Report

2023-10-19

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea187091-8k_adialpharma.htm iXBRL	8-K	47126
2	FORM OF PRE-FUNDED WARRANT	ea187091ex4-1_adialpharma.htm	EX-4.1	95108
3	FORM OF SERIES A PURCHASE WARRANT	ea187091ex4-2_adialpharma.htm	EX-4.2	98705
4	FORM OF SERIES B PURCHASE WARRANT	ea187091ex4-3_adialpharma.htm	EX-4.3	98532
5	FORM OF PLACEMENT AGENT WARRANT	ea187091ex4-4_adialpharma.htm	EX-4.4	98152
6	FORM OF SECURITIES PURCHASE AGREEMENT, DATED OCTOBER 19, 2023, BY AND BETWEEN AD	ea187091ex10-1_adialpharma.htm	EX-10.1	259777
7	FORM OF REGISTRATION RIGHTS AGREEMENT, DATED OCTOBER 19, 2023, BY AND BETWEEN AD	ea187091ex10-2_adialpharma.htm	EX-10.2	134556
8	PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ON OCTOBER 20, 2023	ea187091ex99-1_adialpharma.htm	EX-99.1	12518
9	PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ON OCTOBER 24, 2023	ea187091ex99-2_adialpharma.htm	EX-99.2	12685
	Complete submission text file	0001013762-23-006323.txt		1244055

Data Files

Seq	Description	Document	Type	Size
10	XBRL SCHEMA FILE	adil-20231019.xsd	EX-101.SCH	3024
11	XBRL LABEL FILE	adil-20231019_lab.xml	EX-101.LAB	34240
12	XBRL PRESENTATION FILE	adil-20231019_pre.xml	EX-101.PRE	22365
14	EXTRACTED XBRL INSTANCE DOCUMENT	ea187091-8k_adialpharma_htm.xml	XML	3396

Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901

Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800

ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)